Origen de la red de primer grado T.J. Crawford.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
| Public Company | Medical Specialties | 21 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a T.J. Crawford a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| AMERICAN INTERNATIONAL GROUP, INC. | Multi-Line Insurance | Director/Board Member Human Resources Officer | |
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Medical Specialties | Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member General Counsel Director/Board Member Director/Board Member Director/Board Member Director/Board Member | |
Schering-Plough Corp.
 Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| LINEAGE CELL THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
| NEWELL BRANDS INC. | Industrial Conglomerates | Director/Board Member Director/Board Member | |
| RADIUS HEALTH, INC. | Biotechnology | Director/Board Member | |
AqueSys, Inc.
 AqueSys, Inc. Medical SpecialtiesHealth Technology AqueSys, Inc. is a clinical-stage medical device company that develops ocular implants that reduce intraocular pressure (IOP) associated with glaucoma. It focuses on commercializing implantable devices that will significantly improve the treatment of glaucoma. The company was founded by Charles E. Larsen in 2006 and is headquartered in Parsippany, NJ | Medical Specialties | Chief Executive Officer | |
| ZELTIQ AESTHETICS INC | Medical Specialties | Chief Executive Officer | |
| Icahn Capital LP | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal | |
Naurex, Inc.
 Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Pharmaceuticals: Major | President | |
HistoSonics, Inc.
 HistoSonics, Inc. Medical SpecialtiesHealth Technology HistoSonics, Inc. develops medical devices. The company was founded by Christine Gibbons, Jim Bertolina, Zhen Xu, William Robert, Hall Timothy, J. Brian Fowlkes, Thomas W. Davison, and Charles Cain in November 2009 and is headquartered in Ann Arbor, MI. | Medical Specialties | Director/Board Member | |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member | |
| ASTERIAS BIOTHERAPEUTICS INC | Biotechnology | Director/Board Member | |
Innocrin Pharmaceuticals Holdings LLC
 Innocrin Pharmaceuticals Holdings LLC Medical SpecialtiesHealth Technology Innocrin Pharmaceuticals Holdings LLC discovers and develops oral inhibitors for the treatment of Castration-Resistant Prostate Cancer (CRPC). The company is headquartered in Durham, NC. | Medical Specialties | Director/Board Member | |
| University of Pennsylvania | College/University | Undergraduate Degree | |
The Public Sector Pension Investment Board
 The Public Sector Pension Investment Board Investment ManagersFinance The Public Sector Pension Investment Board (PSP Investments), locally known as Office d'investissement des régimes de pensions du secteur public, is a government-owned pension fund manager headquartered in Montreal, Canada. The firm was founded by the Public Sector Pension Investment Board Act in 1999. PSP Investments invest funds for the pension plans of the federal public service, the Canadian Armed Forces, the Royal Canadian Mounted Police and the Reserve Force. | Investment Managers | Director of Finance/CFO | |
| New York University | College/University | Director/Board Member Doctorate Degree Graduate Degree | |
| St. Joseph's University | College/University | Undergraduate Degree | |
| Baruch College | College/University | Graduate Degree | |
| INOVIO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Human Resources Officer | |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Investment Trusts/Mutual Funds | Director/Board Member | |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | General Government | Corporate Officer/Principal | |
| Bogazici University | College/University | Undergraduate Degree | |
Banyan Biomarkers, Inc.
 Banyan Biomarkers, Inc. Medical/Nursing ServicesHealth Services Banyan Biomarkers, Inc. engages in the commercialization of vitro diagnostic tests for the detection of brain injury and neurological diseases. It develops blood test to accurately and quickly diagnose traumatic brain injury. The company was founded by Nancy Denslow, Ronald L. Hayes, and Kevin Wang in 2002 and is headquartered in San Diego, CA. | Medical/Nursing Services | Director/Board Member | |
| DANA INCORPORATED | Auto Parts: OEM | Director/Board Member Director/Board Member | |
Manhattan Institute For Policy Research, Inc.
 Manhattan Institute For Policy Research, Inc. Miscellaneous Commercial ServicesCommercial Services Manhattan Institute For Policy Research, Inc. develops and disseminate new ideas for greater economic choice and individual responsibility. It focuses on economic growth, education, energy and environment, health care, legal reform, public sector, race and urban policy. The company was founded by Antony Fisher and William J. Casey in 1977 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| ALLERGAN PLC | Pharmaceuticals: Major | Chief Executive Officer General Counsel Public Communications Contact Human Resources Officer Compliance Officer | |
| BAUSCH HEALTH COMPANIES INC. | Pharmaceuticals: Other | Director of Finance/CFO Chairman Director/Board Member Investor Relations Contact Director/Board Member Director/Board Member Director/Board Member General Counsel Director/Board Member Public Communications Contact Corporate Officer/Principal | |
| Allergan Foundation | Director/Board Member Director/Board Member | ||
| Reagan-udall Foundation | Director/Board Member | ||
| ONCOCYTE CORPORATION | Biotechnology | Director/Board Member | |
| National Comprehensive Cancer Network Foundation | Director/Board Member | ||
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Georgetown University School of Medicine | College/University | Doctorate Degree | |
| Samaritan Health Initiatives, Inc. | President | ||
Wavebreak Therapeutics Ltd.
 Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Celularity, Inc. (United States)
 Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
| Reeve-Irvine Research Center | Corporate Officer/Principal | ||
| THE BEAUTY HEALTH COMPANY | Medical Specialties | Chairman Corporate Officer/Principal | |
| CELULARITY INC. | Miscellaneous Commercial Services | Director/Board Member | |
Allergan Plc
 Allergan Plc Pharmaceuticals: MajorHealth Technology Allergan Plc is a global pharmaceutical company that develops, manufactures, and markets branded pharmaceutical, device, biologic, surgical, and regenerative medicine products for patients worldwide. The private company is based in Madison, NJ, with operations in approximately 100 countries. The company has a broad portfolio of leading brands and products in various therapeutic categories, including central nervous system, eye care, medical aesthetics, dermatology, gastroenterology, women's health, urology, and anti-infective. Allergan is an industry leader in open science, a model of research and development that focuses on identifying and developing innovative ideas and innovation for better patient care. | Pharmaceuticals: Major | President Human Resources Officer | |
Convenet Ltd.
 Convenet Ltd. Information Technology ServicesTechnology Services Part of Datavant, Inc., Convenet Ltd. is a technology company that provides NHS integration APIs to businesses of all sizes, from startups to large UK healthcare providers. The company is based in Ripley, UK. Convenet's APIs help startups accelerate the development of their products and enable larger businesses to quickly achieve interoperability with NHS systems. The British company's long-term goal is to empower companies to build scalable NHS integrated products and services that ultimately improve the healthcare experience for all. The company was founded in 2020 by Christopher James Turner and Andrew Vincent Bailey. Convenet was acquired by Datavant, Inc. in 2022. | Information Technology Services | Director/Board Member | |
| TRISALUS LIFE SCIENCES, INC. | Medical Specialties | Director/Board Member | |
Innocrin Pharmaceuticals, Inc.
 Innocrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Innocrin Pharmaceuticals, Inc. develops oral inhibitors for the treatment of castration-resistant prostate cancer. It develops small molecule CYP17 lyase-selective inhibitors to treat resistant hormonally-dependent breast and prostate cancers. The firm’s product under pipeline is VT-464, a dual mechanism lyase-selective CYP17 inhibitor and androgen receptor (AR) antagonist that disrupts the validated biochemical pathways required for prostate cancer growth androgen biosynthesis and AR transcriptional signaling. The company was founded in 2004 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 44 |
| Irlanda | 3 |
| Canadá | 3 |
| Reino Unido | 3 |
| Turquía | 2 |
Sectorial
| Health Technology | 25 |
| Consumer Services | 8 |
| Finance | 4 |
| Commercial Services | 4 |
| Producer Manufacturing | 3 |
Operativa
| Director/Board Member | 156 |
| Independent Dir/Board Member | 53 |
| Corporate Officer/Principal | 47 |
| President | 25 |
| Undergraduate Degree | 19 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Brenton Saunders | 38 |
| Ambrose Bailey | 32 |
| Andrew von Eschenbach | 32 |
| John Paulson | 20 |
| Brett Icahn | 19 |
| Sarah Kavanagh | 19 |
| Karen Ling | 18 |
| Russel Robertson | 16 |
| Thomas Ross | 16 |
| Gary Hu | 13 |
| Nathalie Bernier | 12 |
| Manisha A. Narasimhan | 12 |
| Sam Eldessouky | 11 |
| Seana-Lyn Carson | 7 |
| Yehia Hashad | 7 |
- Bolsa de valores
- Insiders
- T.J. Crawford
- Conexiones Empresas